Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Cerebral malaria is associated with differential cytoadherence to brain endothelial cells.

Storm J, Jespersen JS, Seydel KB, Szestak T, Mbewe M, Chisala NV, Phula P, Wang CW, Taylor TE, Moxon CA, Lavstsen T, Craig AG.

EMBO Mol Med. 2019 Feb;11(2). pii: e9164. doi: 10.15252/emmm.201809164.

2.

Comparative 1D Blue-Native electrophoresis analysis of Plasmodium falciparum and human proteins associated with cytoadherence.

Wu Y, Wagstaff SC, Al-Harthi SA, Craig AG.

Malar J. 2018 Aug 13;17(1):293. doi: 10.1186/s12936-018-2445-8.

3.

Brain microvascular endothelial-astrocyte cell responses following Japanese encephalitis virus infection in an in vitro human blood-brain barrier model.

Patabendige A, Michael BD, Craig AG, Solomon T.

Mol Cell Neurosci. 2018 Jun;89:60-70. doi: 10.1016/j.mcn.2018.04.002. Epub 2018 Apr 7.

4.

Neurovascular sequestration in paediatric P. falciparum malaria is visible clinically in the retina.

Barrera V, MacCormick IJC, Czanner G, Hiscott PS, White VA, Craig AG, Beare NAV, Culshaw LH, Zheng Y, Biddolph SC, Milner DA, Kamiza S, Molyneux ME, Taylor TE, Harding SP.

Elife. 2018 Mar 26;7. pii: e32208. doi: 10.7554/eLife.32208.

5.

In silico guided reconstruction and analysis of ICAM-1-binding var genes from Plasmodium falciparum.

Carrington E, Otto TD, Szestak T, Lennartz F, Higgins MK, Newbold CI, Craig AG.

Sci Rep. 2018 Feb 19;8(1):3282. doi: 10.1038/s41598-018-21591-8.

6.

A semi-synthetic glycosaminoglycan analogue inhibits and reverses Plasmodium falciparum cytoadherence.

Skidmore MA, Mustaffa KMF, Cooper LC, Guimond SE, Yates EA, Craig AG.

PLoS One. 2017 Oct 18;12(10):e0186276. doi: 10.1371/journal.pone.0186276. eCollection 2017.

7.

In vitro inhibition and reversal of Plasmodium falciparum cytoadherence to endothelium by monoclonal antibodies to ICAM-1 and CD36.

Mustaffa KMF, Storm J, Whittaker M, Szestak T, Craig AG.

Malar J. 2017 Jul 5;16(1):279. doi: 10.1186/s12936-017-1930-9.

8.

Brugia malayi microfilariae adhere to human vascular endothelial cells in a C3-dependent manner.

Schroeder JH, McCarthy D, Szestak T, Cook DA, Taylor MJ, Craig AG, Lawson C, Lawrence RA.

PLoS Negl Trop Dis. 2017 May 8;11(5):e0005592. doi: 10.1371/journal.pntd.0005592. eCollection 2017 May.

9.

A quantitative brain map of experimental cerebral malaria pathology.

Strangward P, Haley MJ, Shaw TN, Schwartz JM, Greig R, Mironov A, de Souza JB, Cruickshank SM, Craig AG, Milner DA Jr, Allan SM, Couper KN.

PLoS Pathog. 2017 Mar 8;13(3):e1006267. doi: 10.1371/journal.ppat.1006267. eCollection 2017 Mar.

10.

HIV coinfection influences the inflammatory response but not the outcome of cerebral malaria in Malawian children.

Mbale EW, Moxon CA, Mukaka M, Chagomerana M, Glover S, Chisala N, Omar S, Molyneux M, Seydel K, Craig AG, Taylor T, Heyderman RS, Mallewa M.

J Infect. 2016 Sep;73(3):189-99. doi: 10.1016/j.jinf.2016.05.012. Epub 2016 Jun 14. Review.

11.

Tumor necrosis factor reduces Plasmodium falciparum growth and activates calcium signaling in human malaria parasites.

Cruz LN, Wu Y, Ulrich H, Craig AG, Garcia CR.

Biochim Biophys Acta. 2016 Jul;1860(7):1489-97. doi: 10.1016/j.bbagen.2016.04.003. Epub 2016 Apr 11.

12.

An external sensing system in Plasmodium falciparum-infected erythrocytes.

Wu Y, Cruz LN, Szestak T, Laing G, Molyneux GR, Garcia CR, Craig AG.

Malar J. 2016 Feb 19;15:103. doi: 10.1186/s12936-016-1144-6.

13.

Correction: An Analysis of the Binding Characteristics of a Panel of Recently Selected ICAM-1 Binding Plasmodium falciparum Patient Isolates.

Madkhali AM, Alkurbi MO, Szestak T, Bengtsson A, Patil PR, Wu Y, Alharthi S, Jensen AT, Pleass R, Craig AG.

PLoS One. 2016 Feb 5;11(2):e0148836. doi: 10.1371/journal.pone.0148836. eCollection 2016. No abstract available.

14.

Marked elevation in plasma osteoprotegerin constitutes an early and consistent feature of cerebral malaria.

O'Regan N, Moxon C, Gegenbauer K, O'Sullivan JM, Chion A, Smith OP, Preston RJ, Brophy TM, Craig AG, O'Donnell JS.

Thromb Haemost. 2016 Apr;115(4):773-80. doi: 10.1160/TH15-10-0796. Epub 2016 Jan 14.

15.

A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria.

O'Regan N, Gegenbauer K, O'Sullivan JM, Maleki S, Brophy TM, Dalton N, Chion A, Fallon PG, Grau GE, Budde U, Smith OP, Craig AG, Preston RJ, O'Donnell JS.

Blood. 2016 Mar 3;127(9):1192-201. doi: 10.1182/blood-2015-07-654921. Epub 2015 Oct 28.

16.

Workshop report: Malaria vaccine development in Europe--preparing for the future.

Viebig NK, D'Alessio F, Draper SJ, Sim BK, Mordmüller B, Bowyer PW, Luty AJ, Jungbluth S, Chitnis CE, Hill AV, Kremsner P, Craig AG, Kocken CH, Leroy O.

Vaccine. 2015 Nov 17;33(46):6137-44. doi: 10.1016/j.vaccine.2015.09.074. Epub 2015 Oct 1. Review.

PMID:
26431986
17.

Differential PfEMP1 expression is associated with cerebral malaria pathology.

Tembo DL, Nyoni B, Murikoli RV, Mukaka M, Milner DA, Berriman M, Rogerson SJ, Taylor TE, Molyneux ME, Mandala WL, Craig AG, Montgomery J.

PLoS Pathog. 2014 Dec 4;10(12):e1004537. doi: 10.1371/journal.ppat.1004537. eCollection 2014 Dec.

18.

An analysis of the binding characteristics of a panel of recently selected ICAM-1 binding Plasmodium falciparum patient isolates.

Madkhali AM, Alkurbi MO, Szestak T, Bengtsson A, Patil PR, Wu Y, Al-Harthi SA, Jensen AT, Pleass R, Craig AG.

PLoS One. 2014 Oct 31;9(10):e111518. doi: 10.1371/journal.pone.0111518. eCollection 2014. Erratum in: PLoS One. 2016;11(2):e0148836. Alharthi, Saeed [corrected to Al-Harthi, Saeed A].

19.

Severity of retinopathy parallels the degree of parasite sequestration in the eyes and brains of malawian children with fatal cerebral malaria.

Barrera V, Hiscott PS, Craig AG, White VA, Milner DA, Beare NA, MacCormick IJ, Kamiza S, Taylor TE, Molyneux ME, Harding SP.

J Infect Dis. 2015 Jun 15;211(12):1977-86. doi: 10.1093/infdis/jiu592. Epub 2014 Oct 28.

20.

Pathogenesis of cerebral malaria--inflammation and cytoadherence.

Storm J, Craig AG.

Front Cell Infect Microbiol. 2014 Jul 29;4:100. doi: 10.3389/fcimb.2014.00100. eCollection 2014. Review.

21.

Evidence of promiscuous endothelial binding by Plasmodium falciparum-infected erythrocytes.

Esser C, Bachmann A, Kuhn D, Schuldt K, Förster B, Thiel M, May J, Koch-Nolte F, Yáñez-Mó M, Sánchez-Madrid F, Schinkel AH, Jalkanen S, Craig AG, Bruchhaus I, Horstmann RD.

Cell Microbiol. 2014 May;16(5):701-8. doi: 10.1111/cmi.12270. Epub 2014 Feb 24.

22.

Persistent endothelial activation and inflammation after Plasmodium falciparum Infection in Malawian children.

Moxon CA, Chisala NV, Wassmer SC, Taylor TE, Seydel KB, Molyneux ME, Faragher B, Kennedy N, Toh CH, Craig AG, Heyderman RS.

J Infect Dis. 2014 Feb 15;209(4):610-5. doi: 10.1093/infdis/jit419. Epub 2013 Sep 17.

23.

Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children.

Moxon CA, Wassmer SC, Milner DA Jr, Chisala NV, Taylor TE, Seydel KB, Molyneux ME, Faragher B, Esmon CT, Downey C, Toh CH, Craig AG, Heyderman RS.

Blood. 2013 Aug 1;122(5):842-51. doi: 10.1182/blood-2013-03-490219. Epub 2013 Jun 5.

24.

A simple protocol for platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes in a resource poor setting.

Tembo DL, Montgomery J, Craig AG, Wassmer SC.

J Vis Exp. 2013 May 16;(75):e4316. doi: 10.3791/4316.

25.

Molecular architecture of a complex between an adhesion protein from the malaria parasite and intracellular adhesion molecule 1.

Brown A, Turner L, Christoffersen S, Andrews KA, Szestak T, Zhao Y, Larsen S, Craig AG, Higgins MK.

J Biol Chem. 2013 Feb 22;288(8):5992-6003. doi: 10.1074/jbc.M112.416347. Epub 2013 Jan 6.

26.

Cytoadherence and severe malaria.

Craig AG, Khairul MF, Patil PR.

Malays J Med Sci. 2012 Apr;19(2):5-18.

27.

Signal transduction in Plasmodium-Red Blood Cells interactions and in cytoadherence.

Cruz LN, Wu Y, Craig AG, Garcia CR.

An Acad Bras Cienc. 2012 Jun;84(2):555-72. Epub 2012 May 24.

28.

Cerebral malaria pathogenesis: revisiting parasite and host contributions.

Grau GE, Craig AG.

Future Microbiol. 2012 Feb;7(2):291-302. doi: 10.2217/fmb.11.155. Review.

PMID:
22324996
29.

The role of animal models for research on severe malaria.

Craig AG, Grau GE, Janse C, Kazura JW, Milner D, Barnwell JW, Turner G, Langhorne J; participants of the Hinxton Retreat meeting on Animal Models for Research on Severe Malaria.

PLoS Pathog. 2012 Feb;8(2):e1002401. doi: 10.1371/journal.ppat.1002401. Epub 2012 Feb 2. No abstract available.

30.

Cytoadherence and virulence - the case of Plasmodium knowlesi malaria.

Fatih FA, Siner A, Ahmed A, Woon LC, Craig AG, Singh B, Krishna S, Cox-Singh J.

Malar J. 2012 Feb 3;11:33. doi: 10.1186/1475-2875-11-33.

31.

Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate.

Patil PR, Gemma S, Campiani G, Craig AG.

Malar J. 2011 Dec 1;10:348. doi: 10.1186/1475-2875-10-348.

32.

Elevated plasma von Willebrand factor and propeptide levels in Malawian children with malaria.

Phiri HT, Bridges DJ, Glover SJ, van Mourik JA, de Laat B, M'baya B, Taylor TE, Seydel KB, Molyneux ME, Faragher EB, Craig AG, Bunn JE.

PLoS One. 2011;6(11):e25626. doi: 10.1371/journal.pone.0025626. Epub 2011 Nov 17.

33.

European Vaccine Initiative: lessons from developing malaria vaccines.

Geels MJ, Imoukhuede EB, Imbault N, van Schooten H, McWade T, Troye-Blomberg M, Dobbelaer R, Craig AG, Leroy O.

Expert Rev Vaccines. 2011 Dec;10(12):1697-708. doi: 10.1586/erv.11.158. Review.

PMID:
22085173
34.

Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses.

Bhatt TK, Khan S, Dwivedi VP, Banday MM, Sharma A, Chandele A, Camacho N, Ribas de Pouplana L, Wu Y, Craig AG, Mikkonen AT, Maier AG, Yogavel M, Sharma A.

Nat Commun. 2011 Nov 8;2:530. doi: 10.1038/ncomms1522.

PMID:
22068597
35.

Amplification of P. falciparum Cytoadherence through induction of a pro-adhesive state in host endothelium.

Wu Y, Szestak T, Stins M, Craig AG.

PLoS One. 2011;6(10):e24784. doi: 10.1371/journal.pone.0024784. Epub 2011 Oct 17.

36.

Malaria: modification of the red blood cell and consequences in the human host.

Moxon CA, Grau GE, Craig AG.

Br J Haematol. 2011 Sep;154(6):670-9. doi: 10.1111/j.1365-2141.2011.08755.x. Epub 2011 May 28. Review.

37.

Automated counting for Plasmodium falciparum cytoadherence experiments.

Paton D, Faragher B, Mustaffa KM, Szestak T, Barrett SD, Craig AG.

Malar J. 2011 Apr 16;10:91. doi: 10.1186/1475-2875-10-91.

38.

Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.

Ochola LB, Siddondo BR, Ocholla H, Nkya S, Kimani EN, Williams TN, Makale JO, Liljander A, Urban BC, Bull PC, Szestak T, Marsh K, Craig AG.

PLoS One. 2011 Mar 3;6(3):e14741. doi: 10.1371/journal.pone.0014741.

39.

Vascular endothelial cells cultured from patients with cerebral or uncomplicated malaria exhibit differential reactivity to TNF.

Wassmer SC, Moxon CA, Taylor T, Grau GE, Molyneux ME, Craig AG.

Cell Microbiol. 2011 Feb;13(2):198-209. doi: 10.1111/j.1462-5822.2010.01528.x. Epub 2010 Oct 7.

40.

Malaria vaccines - how and when to proceed?

Craig AG, Holder AA, Leroy OY, Ventura RA; European Network for Harmonisation of Malaria Vaccine Development (EURHAVAC).

Trends Parasitol. 2009 Dec;25(12):535-7. doi: 10.1016/j.pt.2009.09.005. Epub 2009 Oct 17.

PMID:
19837633
41.

Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment.

Hughes KR, Biagini GA, Craig AG.

Mol Biochem Parasitol. 2010 Feb;169(2):71-8. doi: 10.1016/j.molbiopara.2009.09.007. Epub 2009 Oct 1.

42.

Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.

Larkin D, de Laat B, Jenkins PV, Bunn J, Craig AG, Terraube V, Preston RJ, Donkor C, Grau GE, van Mourik JA, O'Donnell JS.

PLoS Pathog. 2009 Mar;5(3):e1000349. doi: 10.1371/journal.ppat.1000349. Epub 2009 Mar 20.

43.

Host response to cytoadherence in Plasmodium falciparum.

Chakravorty SJ, Hughes KR, Craig AG.

Biochem Soc Trans. 2008 Apr;36(Pt 2):221-8. doi: 10.1042/BST0360221. Review.

PMID:
18363564
44.

Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives possessing reduced anticoagulant and other serine protease inhibition activities.

Skidmore MA, Dumax-Vorzet AF, Guimond SE, Rudd TR, Edwards EA, Turnbull JE, Craig AG, Yates EA.

J Med Chem. 2008 Mar 13;51(5):1453-8. doi: 10.1021/jm701337t. Epub 2008 Feb 9.

PMID:
18260612
45.

Impact of human immunodeficiency virus infection in pregnant women on variant-specific immunity to malaria.

Dembo EG, Mwapasa V, Montgomery J, Craig AG, Porter KA, Meshnick SR, Molyneux ME, Rogerson SJ.

Clin Vaccine Immunol. 2008 Apr;15(4):617-21. doi: 10.1128/CVI.00378-07. Epub 2008 Jan 16.

46.

Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: pathogenic or protective?

Chakravorty SJ, Carret C, Nash GB, Ivens A, Szestak T, Craig AG.

Int J Parasitol. 2007 Jul;37(8-9):975-87. Epub 2007 Feb 20.

47.

The effect of Plasmodium falciparum infection on expression of monocyte surface molecules.

Jenkins NE, Chakravorty SJ, Urban BC, Kai OK, Marsh K, Craig AG.

Trans R Soc Trop Med Hyg. 2006 Nov;100(11):1007-12. Epub 2006 Jun 12.

PMID:
16765392
48.

Genetic analysis of circulating and sequestered populations of Plasmodium falciparum in fatal pediatric malaria.

Montgomery J, Milner DA Jr, Tse MT, Njobvu A, Kayira K, Dzamalala CP, Taylor TE, Rogerson SJ, Craig AG, Molyneux ME.

J Infect Dis. 2006 Jul 1;194(1):115-22. Epub 2006 May 31.

PMID:
16741890
49.

A polymorphism of intercellular adhesion molecule-1 is associated with a reduced incidence of nonmalarial febrile illness in Kenyan children.

Jenkins NE, Mwangi TW, Kortok M, Marsh K, Craig AG, Williams TN.

Clin Infect Dis. 2005 Dec 15;41(12):1817-9. Epub 2005 Nov 8.

50.

Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post-translationally modified conotoxin, reveals that the glycan structure is alpha-D-Gal-(1-->3)-alpha-D-GalNAc.

Kang J, Low W, Norberg T, Meisenhelder J, Hansson K, Stenflo J, Zhou GP, Imperial J, Olivera BM, Rigby AC, Craig AG.

Eur J Biochem. 2004 Dec;271(23-24):4939-49.

Supplemental Content

Loading ...
Support Center